Blair Ian P, Mitchell Philip B, Schofield Peter R
School of Psychiatry, University of New South Wales and Black Dog Institute, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia.
Aust N Z J Psychiatry. 2005 Jul;39(7):542-9. doi: 10.1080/j.1440-1614.2005.01625.x.
Most psychiatric disorders are complex genetic traits involving both genetic and environmental risk factors. This paper aims to review the gene identification strategies being applied by molecular geneticists in their efforts to elucidate the genetic and molecular basis of psychiatric disorders. Future strategies will also be canvassed.
The psychiatric genetic literature was reviewed to identify current strategies applied to gene identification, with examples provided where available. The future strategies and applications that will arise from genome projects, including the International Haplotype Mapping Project, are also discussed.
Many advances in the techniques of gene discovery, and the increasing resources available, are rapidly being adopted by researchers and applied to the complex problem of identifying susceptibility genes for mental illnesses. Perhaps the single most important advance to date is the Human Genome Project and all that has stemmed from the vast quantity of information that this endeavour has provided. With these technological advances and the massive increase of publicly available genetic resources, several genes have recently been implicated in the susceptibility to psychiatric illnesses including schizophrenia and depression. After many years of fruitless endeavours, these recent reports indicate that the labours of researchers in psychiatric genetics are beginning to show exciting results.
Identification of these susceptibility genes holds great promise, with the unravelling of the molecular and biochemical basis of some conditions now being a more realistic and tangible goal. The increasing number of genes being identified augers well for the future treatment of psychiatric disorders. The genes identified, and the pathways of genes and proteins that they implicate, will provide potential novel targets for new therapeutic drugs. Psychiatric genetics appears to be poised for significant advances in our knowledge and understanding of the molecular genetic basis of mental illness.
大多数精神疾病是复杂的遗传性状,涉及遗传和环境风险因素。本文旨在综述分子遗传学家为阐明精神疾病的遗传和分子基础而采用的基因识别策略。同时也将探讨未来的策略。
回顾精神遗传学文献,以确定当前应用于基因识别的策略,并在可行的情况下提供实例。还讨论了包括国际单倍型图谱计划在内的基因组计划将带来的未来策略和应用。
基因发现技术取得了许多进展,可用资源也不断增加,研究人员迅速采用这些成果,并将其应用于识别精神疾病易感基因这一复杂问题。迄今为止,或许最重要的进展当属人类基因组计划以及由此产生的海量信息。随着这些技术进步以及公开可用遗传资源的大量增加,最近已有多个基因被认为与精神疾病(包括精神分裂症和抑郁症)的易感性有关。经过多年的无果努力,这些最新报告表明,精神遗传学研究人员的工作开始展现出令人振奋的成果。
识别这些易感基因前景广阔,目前揭示某些疾病的分子和生化基础已成为一个更现实、更具体的目标。越来越多的基因被识别出来,这对精神疾病的未来治疗是个好兆头。已识别的基因及其所涉及的基因和蛋白质途径,将为新型治疗药物提供潜在的新靶点。精神遗传学似乎即将在我们对精神疾病分子遗传基础的认识和理解方面取得重大进展。